KAIST Develops One-Second Gel-forming Hemostatic Powder for Military and Emergency Use
KAIST has introduced 'AGCL Powder,' a hemostatic agent that forms a hydrogel barrier in just one second upon application to wounds. Composed of biocompatible materials, it absorbs over 725% of its weight in blood and features a low hemolysis rate and significant antibacterial properties, making it suitable for military and emergency medical use. Developed with insights from Army major Park Gyu-soon, the powder aims to reduce casualties in combat and enhance civilian medical care.
Theia Market Signal Identification - AI Assisted
KAIST has developed 'AGCL Powder,' a hemostatic agent that forms a hydrogel barrier within one second when applied to wounds. The powder is a blend of biocompatible materials like alginate and chitosan, reacting with blood cations to seal wounds instantly.
It can absorb over 725% of its weight in blood and withstands pressures exceeding 40kPa. With a hemolysis rate below 3% and an antibacterial effect of 99.9%, it shows promising tissue regeneration capabilities.
The powder maintains efficacy for two years under various conditions, making it suitable for military operations and disaster response. Developed with input from Army major Park Gyu-soon, the technology aims to minimize casualties in combat and can also be used in emergency medical situations, extending its application from the battlefield to civilian medical care.
Comments